A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo | Semantic Scholar Skip to search formSkip to main content> Semantic Scholar's Logo Search Sign InCreate Free Account You are currently offline. Some features of the site may not work correctly. DOI:10.1159/000433424 Corpus ID: 20648420A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo @article{Singh2015ARC, title={A Randomized Comparative Study of Oral Corticosteroid Minipulse and Low-Dose Oral Methotrexate in the Treatment of Unstable Vitiligo}, author={H. Singh and M. Kumaran and A. Bains and D. Parsad}, journal={Dermatology}, year={2015}, volume={231}, pages={286 - 290} } H. Singh, M. Kumaran, +1 author D. Parsad Published 2015 Medicine Dermatology Background: Despite continued progress towards elucidation of the biochemical, genetic and immunopathological pathways in vitiligo, a definitive cure remains elusive. The initial therapy must be directed to arrest disease progression. Oral minipulse therapy (OMP) with betamethasone/dexamethasone has been tried and shown to be an effective modality to arrest the disease progression in vitiligo. Objectives: Methotrexate (MTX) is a time-tested effective treatment extensively used in various… Expand View on PubMed doi.org Save to Library Create Alert Cite Launch Research Feed Share This Paper 28 CitationsBackground Citations 8 View All Topics from this paper Methotrexate Dexamethasone Adrenal Cortex Hormones Betamethasone Autoimmune Diseases Omeprazole Unstable Medical Device Problem Paget's Disease, Mammary Angina, Unstable Disease Progression 28 Citations Citation Type Citation Type All Types Cites Results Cites Methods Cites Background Has PDF Publication Type Author More Filters More Filters Filters Sort by Relevance Sort by Most Influenced Papers Sort by Citation Count Sort by Recency Oral mycophenolate mofetil as a stabilizing treatment for progressive non-segmental vitiligo: results from a prospective, randomized, investigator-blinded pilot study A. Bishnoi, K. Vinay, M. Kumaran, D. Parsad Medicine Archives of Dermatological Research 2020 Save Alert Research Feed Combination of oral methotrexate and oral mini‐pulse dexamethasone vs either agent alone in vitiligo treatment with follow up by dermoscope M. ElGhareeb, M. Metwally, N. Abdelmoneim Medicine Dermatologic therapy 2020 1 Save Alert Research Feed Topical methotrexate 1% gel for treatment of vitiligo: A case report and review of the literature A. Abdelmaksoud, D. Dave, T. Lotti, M. Vestita Medicine Dermatologic therapy 2019 4 Save Alert Research Feed Vitiligo: an update on systemic treatments T. Searle, F. Al-Niaimi, F. Ali Medicine Clinical and experimental dermatology 2020 Save Alert Research Feed Emerging drugs for the treatment of vitiligo A. Vojvodic, Priyanka Karagaiah, +8 authors T. Lotti Medicine Expert opinion on emerging drugs 2020 1 View 1 excerpt, cites background Save Alert Research Feed Addition of oral minipulse dexamethasone to narrowband ultraviolet B phototherapy and topical steroids helps arrest disease activity in patients with vitiligo A. Tovar-Garza, J. Hinojosa, L. Hynan, A. Pandya Medicine The British journal of dermatology 2019 5 Save Alert Research Feed Advances in Vitiligo: An Update on Medical and Surgical Treatments. A. B. Dillon, Andrew Sideris, A. Hadi, N. Elbuluk Medicine The Journal of clinical and aesthetic dermatology 2017 18 Save Alert Research Feed Statins role in vitiligo: A mini-review Hayder M Al-Kuraishy, Nawar Hussian, M. Al-Naimi, Ali I. Al-Gareeb Medicine 2020 2 View 1 excerpt, cites background Save Alert Research Feed What’s in the Pipeline for Melasma and Vitiligo N. Elbuluk, P. Grimes Medicine 2017 3 Save Alert Research Feed Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy K. Boniface, J. Seneschal, M. Picardo, A. Taïeb Biology, Medicine Clinical Reviews in Allergy & Immunology 2017 74 View 1 excerpt, cites background Save Alert Research Feed ... 1 2 3 ... References SHOWING 1-10 OF 31 REFERENCES SORT BYRelevance Most Influenced Papers Recency Low-Dose Oral Mini-Pulse Dexamethasone Therapy in Progressive Unstable Vitiligo A. Kanwar, R. Mahajan, D. Parsad Medicine Journal of cutaneous medicine and surgery 2013 31 Save Alert Research Feed The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patient. K. Banerjee, J. N. Barbhuiya, A. Ghosh, S. Dey, P. R. Karmakar Medicine Indian journal of dermatology, venereology and leprology 2003 19 Save Alert Research Feed Oral dexamethasone pulse treatment for vitiligo. S. Radakovic-Fijan, A. M. Fürnsinn-Friedl, H. Hönigsmann, A. Tanew Medicine Journal of the American Academy of Dermatology 2001 102 Save Alert Research Feed Methotrexate for treatment of lichen planus: old drug, new indication A. Kanwar, D. De Medicine Journal of the European Academy of Dermatology and Venereology : JEADV 2013 21 Save Alert Research Feed Oral minipulse therapy in vitiligo. A. Kanwar, S. Dhar, G. Dawn Medicine Dermatology 1995 24 Save Alert Research Feed Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients J. Wenzel, S. Brähler, R. Bauer, T. Bieber, T. Tüting Medicine The British journal of dermatology 2005 99 Save Alert Research Feed Methotrexate for the treatment of generalized vitiligo. K. AlGhamdi, Huma Khurrum Medicine Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society 2013 18 PDF Save Alert Research Feed Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. M. Njoo, P. K. Das, J. Bos, W. Westerhof Medicine Archives of dermatology 1999 149 PDF Save Alert Research Feed ORAL MINI‐PULSE THERAPY WITH BETAMETHASONE IN VITILIGO PATIENTS HAVING EXTENSIVE OR FAST‐SPREADING DISEASE J. S. Pasricha, B. Khaitan Medicine International journal of dermatology 1993 108 Save Alert Research Feed Response to methotrexate in early rheumatoid arthritis is associated with a decrease of T cell derived tumour necrosis factor α, increase of interleukin 10, and predicted by the initial concentration of interleukin 4 M. Rudwaleit, Z. Yin, +4 authors J. Sieper Medicine Annals of the rheumatic diseases 2000 84 PDF Save Alert Research Feed ... 1 2 3 4 ... Related Papers Abstract Topics 28 Citations 31 References Related Papers Stay Connected With Semantic Scholar Sign Up About Semantic Scholar Semantic Scholar is a free, AI-powered research tool for scientific literature, based at the Allen Institute for AI. Learn More → Resources DatasetsSupp.aiAPIOpen Corpus Organization About UsResearchPublishing PartnersData Partners   FAQContact Proudly built by AI2 with the help of our Collaborators Terms of Service•Privacy Policy The Allen Institute for AI By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License ACCEPT & CONTINUE